Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Mayu Omori"'
Autor:
Hiroko Kashiwagi, Kayo Kume, Koji Takeda, Taiki Ueshima, Osamu Asaumi, Mayu Omori, Naotsugu Hirabayashi
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
The global impact of COVID-19 outbreak on psychiatric hospitals and prisons is unfathomable and unprecedented, and information is needed on how best to mitigate widespread infection whilst safeguarding the community's well-being. This study reports o
Externí odkaz:
https://doaj.org/article/7dc5313885aa4c7ba95bbe1c011640ef
Autor:
Hirofumi Nishinaka, Jun Nakane, Takako Nagata, Atsushi Imai, Noriomi Kuroki, Noriko Sakikawa, Mayu Omori, Osamu Kuroda, Naotsugu Hirabayashi, Yoshito Igarashi, Kenji Hashimoto
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0148354 (2016)
BACKGROUND:In Japan, the legislation directing treatment of offenders with psychiatric disorders was enacted in 2005. Neuropsychological impairment is highly related to functional outcomes in patients with psychiatric disorders, and several studies h
Externí odkaz:
https://doaj.org/article/1d31dd531abb4b1b88d6e9da3636b447
Autor:
Keiya Iijima, Mayu Omori, Suguru Yokosako, Yuiko Kimura, Yukiko Kano, Masaki Iwasaki, Yuu Kaneko, Yutaro Takayama, Takanobu Kaido
Publikováno v:
Neurologia medico-chirurgica
The efficacy of deep brain stimulation (DBS) for refractory Tourette syndrome (TS) is accepted, but whether the efficacy of DBS treatment in the Japanese population is equivalent to those reported internationally and whether adverse effects are compa
Autor:
Kenta Yoshida, Takayuki Enomoto, Tomoaki Ikeda, Tsutomu Tabata, Eiji Kondo, Atsuo Itakura, Mayu Omori, Toru Hirata, Masayuki Sekine, Yoshiyuki Kobayashi
Publikováno v:
International Journal of Clinical Oncology. 24:328-333
In recent years, the incidence of malignant disease in pregnancy has been increasing, but there are few large-scale surveys of malignant disease in pregnancy in Japan. The aim of this study was to survey malignant disease occurring during pregnancy i
Autor:
Hisako Taguchi, Kazuyoshi Takeda, Mayu Omori, Atsuko Kadono, Satoru Ikezawa, Kazuhiko Segawa, Naotsugu Hirabayashi, Tomiki Sumiyoshi, Hiroko Kashiwagi
Publikováno v:
Neuropsychiatric Disease and Treatment
We present a case of schizophrenia comorbid for tetralogy of Fallot, without chromosome 22q.11.2 deletion or duplication, treated successfully with a combination of clozapine and antiepileptic drugs. Although clozapine by itself initially triggered c
Autor:
Atsushi Imai, Kenji Hashimoto, Naotsugu Hirabayashi, Yoshito Igarashi, Jun Nakane, Takako Nagata, Noriomi Kuroki, Hirofumi Nishinaka, Osamu Kuroda, Mayu Omori, Noriko Sakikawa
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0148354 (2016)
PLoS ONE
PLoS ONE
BACKGROUND: In Japan, the legislation directing treatment of offenders with psychiatric disorders was enacted in 2005. Neuropsychological impairment is highly related to functional outcomes in patients with psychiatric disorders, and several studies
Publikováno v:
Neuromodulation: Technology at the Neural Interface. 14:123-129
Objective: Refractory Tourette syndrome (TS) disturbs the social life of patients. Deep brain stimulation (DBS) has recently been applied to relieve severe tics. We report a prospective open-labeled case series of DBS for TS as a pilot study. Cases a
Autor:
Misty Richards, Hiroaki Hori, Kunimasa Arima, Tomoko Shizuno, Hiroshi Kunugi, Yoko Kamegaya, Mayu Omori, Yoshimi Iijima, Osamu Saitoh
Publikováno v:
Journal of Neural Transmission. 115:1347-1354
Previous studies suggested that genetic variations in the 5' region of Epsin 4, a gene encoding enthoprotin on chromosome 5q33, are associated with schizophrenia. However, conflicting results have also been reported. We examined the possible associat
Autor:
Ryotaro Tsukue, Ryota Hashimoto, Hiroaki Hori, Shigeo Okabe, Seiichi Harada, Masatoshi Takeda, Masao Iwase, Mayu Omori, Osami Kajimoto, Hiroshi Kunugi, Naotsugu Hirabayashi, Tetsuo Nakabayashi, Sho Takahashi, Kimitaka Anami, Osamu Saitoh, Hiroko Noguchi
Publikováno v:
Schizophrenia research. 86(1-3)
Antipsychotic polypharmacy and excessive dosing still prevail worldwide in the treatment of schizophrenia, while their possible association with cognitive function has not well been examined. We examined whether the "non-standard" use of antipsychoti
Autor:
Kunimasa Arima, T. Okada, Osamu Saitoh, K. Kudo, Akemichi Baba, Hiroaki Hori, Hiroshi Kunugi, Kimitaka Anami, S. Takahashi, Tetsuo Nakabayashi, Naotugu Hirabayashi, Ryoutaro Tsukue, M Tatsumi, Takashi Asada, Kunitoshi Kamijima, Mayu Omori, S. Harada, Asako Kosuga, Ryota Hashimoto
Publikováno v:
Journal of neural transmission (Vienna, Austria : 1996). 113(10)
We examined, for the first time, the possible association between schizophrenia and the anaplastic lymphoma kinase (ALK) gene which plays an important role in neurodevelopment. When two nonsynonymous polymorphisms (Arg1491Lys and Glu1529Asp) were exa